Medinice SA
WSE:ICE
Medinice SA
Medinice SA is engaged in providing cardiological & cardiosurgical devices and solutions. The company is headquartered in Warsaw, Woj. Mazowieckie. The company went IPO on 2018-09-25. The firm specializes in creating, developing and commercializing safe and minimally invasive solutions in the field of medicine, in particular cardiology and cardio surgery. Its portfolio comprises of projects, such as CathAIO, Cryoapplicator, Med-IConsole, Minimax, Pacepress and others. All of the Company's projects have a global potential. The firm cooperates with research centers in Poland and Europe. The company strives to commercialize inventions brought by both co-founders of the Company and acquired projects through the sale of licenses worldwide in the production of medical devices.
Medinice SA is engaged in providing cardiological & cardiosurgical devices and solutions. The company is headquartered in Warsaw, Woj. Mazowieckie. The company went IPO on 2018-09-25. The firm specializes in creating, developing and commercializing safe and minimally invasive solutions in the field of medicine, in particular cardiology and cardio surgery. Its portfolio comprises of projects, such as CathAIO, Cryoapplicator, Med-IConsole, Minimax, Pacepress and others. All of the Company's projects have a global potential. The firm cooperates with research centers in Poland and Europe. The company strives to commercialize inventions brought by both co-founders of the Company and acquired projects through the sale of licenses worldwide in the production of medical devices.